Web Blogs

   
  • Home
  • About Us »
    • + Analyst Access
    • + Methodology
    • + Analyst Bios
    • + Testimonials
  • Consulting »
    • + Competitive Intelligence
    • + Market Sizing & Positioning
    • + Gap Analysis
    • + Strategy Review
    • + New Market Entry
    • + Vendor Selection
  • Research »
    • + Banking
    • + Cross Industry
    • + Insurance
    • + Securities & Investments
    • + Analyst Access
  • News
  • Events
  • Press
  • Blogs »
    • + Banking Blog
    • + Insurance Blog
  • Login

Service Areas

Banking

  • » Retail and Business Banking
  • » Corporate Banking

Corporate

  • » Treasury

Cross-Industry

  • » Asian Financial Services
  • » Indian Financial Services
  • » Finance & Risk
  • » Wealth Management

Insurance

  • » Life/Health
  • » Property/Casualty

Securities & Investments

  • » Capital Markets
  • Contact Us |
  • Careers |
  • Become a client - join our mailing list

Celent

San Francisco, CA, USA
June 29, 2009

HSA Benchmarking Analysis: Market Trends and Economics 2009

Report Published by Celent

Health savings accounts continue to be adopted widely, with an ever-growing number of accounts and assets. Between January 2008 and January 2009, participants in the latest HSA benchmarking survey from Celent experienced a 46.1% increase in the number of HSAs. During the same period, survey participants saw their asset base grow by 62.6%.

This will likely turn out to be the year that significant healthcare reform is written into legislation in the US. Health savings accounts (HSAs) are expected to survive these reforms, and for good reason. If healthcare reforms were to write HSAs out of existence, they would discard all the efforts behind one of the fastest-growing retail banking products today.

One of the main findings of Celent’s most recent HSA benchmarking exercise is the robust growth of HSAs. Other key findings include:

  • Between January 2008 and January 2009, average account balances grew by only 13% to $1,561. This low growth rate can be attributed to a high number of unfunded accounts (accounts with no contributions during the preceding 12 months), which stood at 18%. The reasons for this are the relatively high number of accounts coming online in January 2009 and some banks’ failure to systematically purge inactive accounts.
  • Investments fell of 5% of total assets. This is hardly a surprise, given the recessionary environment, unemployment, and falling investment values. What is quite surprising is that for the larger HSA players, the number of accounts with investment balances barely register; such accounts made up only 1–2% of all accounts.
  • The specialist segment players are enjoying increased revenue per account, up to $84. This growth can be largely traced to improved management of DDA margins/spreads.
  • In terms of distribution, the top 25 and specialist segments are slowing moving to resemble each other. Top 25 players are gaining more sales through health plan channels, and specialists are building more business in the direct-to-employer channel.
  • Debit cards are attached to almost all HSAs, but are only used for 66% of the funds disbursed. Checks continue to hold a good share (20%) of disbursements, while a new disbursement method, integrated payments, accounts for 1% of dollar volumes.

"HSA pricing continues to decline, with average collected monthly fees now hovering just above the $2 mark," says Red Gillen, senior analyst with Celent's Banking group and author of the report. "In fact, some HSA players are even preparing for the eventuality when HSAs go the way of checking accounts. In other words, free."

This research is an update of Celent’s previous HSA benchmarking reports and contains newly collected information. This report measures banks' most relevant HSA performance criteria and provides an analysis of underlying factors and trends.

The 44-page report contains 26 figures A table of contents for this report is available online.

Members of Celent’s Healthcare Banking research service can download the report electronically by clicking the icon to the left. Non-members should contact info@celent.com for more information.

 

About Celent

Celent is a research and advisory firm dedicated to helping financial institutions formulate comprehensive business and technology strategies. Celent publishes reports identifying trends and best practices in financial services technology and conducts consulting engagements for financial institutions looking to use technology to enhance existing business processes or launch new business strategies. With a team of internationally experienced analysts, Celent is uniquely positioned to offer strategic advice and market insights on a global basis. Celent is a member of the Oliver Wyman Group, which is part of Marsh & McLennan Companies [NYSE: MMC].

Media Contacts

New York - Dana Lautin
dlautin@celent.com
Tel.: +1 646 364 8254

Paris - Alexandra Vouge
avouge@celent.com
Tel.: +33.1.73.04.46.26

Tokyo - Yumi Nagaoka
ynagaoka@celent.com
Tel.: +81.3.3596.0020

 
 

Home | Terms of Use
Copyright © 2010 Oliver Wyman

Send mail to info@celent.com with questions or comments about this Web site.